Inspire Advisors LLC Sells 101 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Inspire Advisors LLC trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.0% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 3,222 shares of the medical equipment provider’s stock after selling 101 shares during the period. Inspire Advisors LLC’s holdings in Intuitive Surgical were worth $1,433,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of ISRG. Gilbert & Cook Inc. boosted its holdings in Intuitive Surgical by 6.5% in the fourth quarter. Gilbert & Cook Inc. now owns 3,437 shares of the medical equipment provider’s stock worth $1,160,000 after purchasing an additional 211 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Intuitive Surgical by 0.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 519,807 shares of the medical equipment provider’s stock worth $175,364,000 after acquiring an additional 4,335 shares during the period. Janney Montgomery Scott LLC lifted its holdings in Intuitive Surgical by 5.1% in the fourth quarter. Janney Montgomery Scott LLC now owns 51,301 shares of the medical equipment provider’s stock valued at $17,307,000 after acquiring an additional 2,504 shares during the period. Kingsview Wealth Management LLC boosted its position in Intuitive Surgical by 4.2% in the fourth quarter. Kingsview Wealth Management LLC now owns 4,093 shares of the medical equipment provider’s stock worth $1,381,000 after purchasing an additional 165 shares during the last quarter. Finally, Great Lakes Advisors LLC grew its stake in shares of Intuitive Surgical by 14.7% during the 4th quarter. Great Lakes Advisors LLC now owns 21,253 shares of the medical equipment provider’s stock valued at $7,170,000 after purchasing an additional 2,725 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In related news, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total transaction of $641,382.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total value of $90,655.48. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,655,048.26. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Craig H. Barratt sold 1,400 shares of the business’s stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total transaction of $641,382.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 50,555 shares of company stock valued at $24,267,737. 0.90% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent research reports. Truist Financial boosted their target price on shares of Intuitive Surgical from $450.00 to $515.00 and gave the company a “buy” rating in a research report on Tuesday, July 16th. Barclays boosted their price target on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a report on Thursday, July 18th. BTIG Research raised their price objective on Intuitive Surgical from $469.00 to $494.00 and gave the stock a “buy” rating in a research note on Wednesday, August 28th. Morgan Stanley boosted their price objective on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research note on Monday, July 15th. Finally, Evercore ISI decreased their target price on shares of Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating on the stock in a research note on Friday, July 19th. Six equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $446.45.

Intuitive Surgical Stock Down 0.8 %

Shares of NASDAQ:ISRG opened at $489.86 on Friday. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $496.18. The firm has a fifty day simple moving average of $463.74 and a two-hundred day simple moving average of $421.55. The stock has a market capitalization of $173.75 billion, a P/E ratio of 88.42, a PEG ratio of 5.41 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.24. The firm had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The company’s revenue for the quarter was up 14.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.18 EPS. On average, analysts expect that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.